Adult Vaccines Market Report to 2031: Visiongain Research Inc. Visiongain has published a new report on Adult Vaccines Market Report to 2031: Forecasts By Vaccine (Influenza, Tetanus /Diphtheria/Pertussis, Varicella, Human Papillomavirus, Zoster,...

Vaccine Delivery Devices Market Worth US$ 10.84 Billion by 2031: Visiongain Research Inc Visiongain has published a new report on Vaccine Delivery Devices Market Report 2021 to 2031. Profiles of Vaccine Delivery Devices and Forecasts By Device Type (Syringes, Jet Injectors, Micro Needles,...

ePharmacy Market Size Worth US$370 Million by 2031: Visiongain Research Inc. Visiongain has published a new report on Global ePharmacy Market Report Forecast 2021-2031. Forecasts by Product (Prescription Medicine (Rx) and Over-The-Counter (OTC)). PLUS Profiles of Leading...

AzurRx BioPharma Engages PPD to Manage Clinical Trial for Niclosamide as Treatment for COVID-19 Gastrointestinal Infections Phase 2 Study of oral niclosamide planned for 1H 2021 DELRAY BEACH, Fla., Feb. 09, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage...

COVID-19 Diagnostic Kits and Therapy Market to Reach $13.9 Billion by 2025- Exclusive Report by Meticulous Research® London, June 19, 2020 (GLOBE NEWSWIRE) -- According to a new market research report “COVID-19 Diagnostics (PCR Testing, Antibody Testing) and Therapy (Immunotherapy, Vaccines, Antiviral, Cell-based,...